دورية أكاديمية
أعرض في EDS

Caregiver acceptance of malaria vaccination for children under 5 years of age and associated factors: cross-sectional household survey, Guinea and Sierra Leone, 2022.

التفاصيل البيبلوغرافية
العنوان: Caregiver acceptance of malaria vaccination for children under 5 years of age and associated factors: cross-sectional household survey, Guinea and Sierra Leone, 2022.
المؤلفون: Röbl K; Department of Infectious Disease Epidemiology, Robert Koch-Institute, Seestraße 10, 13353, Berlin, Germany.; Postgraduate Training for Applied Epidemiology (PAE), Robert Koch-Institute, Seestraße 10, 13353, Berlin, Germany.; ECDC Fellowship Programme, Field Epidemiology Path (EPIET), European Centre for Disease Prevention and Control (ECDC), Gustav III:S Boulevard 40, 16973, Solna, Sweden., Fischer HT; Evidence-Based Public Health, Centre for International Health Protection, Robert Koch-Institute, Nordufer 20, 13353, Berlin, Germany.; Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany., Delamou A; Centre d'Excellence Africain pour la Prévention et le Contrôle des Maladies Transmissibles (CEA-PCMT), Université Gamal Abdel Nasser de Conakry (UGANC), Dixinn, PoBox 1017, Conakry, Guinea.; Faculté des sciences techniques de la santé (FSTS), Université Gamal Abdel Nasser de Conakry (UGANC), Conakry, Guinea., Mbawah AK; College of Medicine and Allied Health Sciences (COMAHS), University of Sierra Leone, Connaught Hospital, Freetown, Sierra Leone., Geurts B; Evidence-Based Public Health, Centre for International Health Protection, Robert Koch-Institute, Nordufer 20, 13353, Berlin, Germany., Feddern L; Evidence-Based Public Health, Centre for International Health Protection, Robert Koch-Institute, Nordufer 20, 13353, Berlin, Germany., Baldé H; Centre d'Excellence Africain pour la Prévention et le Contrôle des Maladies Transmissibles (CEA-PCMT), Université Gamal Abdel Nasser de Conakry (UGANC), Dixinn, PoBox 1017, Conakry, Guinea.; Faculté des sciences techniques de la santé (FSTS), Université Gamal Abdel Nasser de Conakry (UGANC), Conakry, Guinea., Kaba I; Centre d'Excellence Africain pour la Prévention et le Contrôle des Maladies Transmissibles (CEA-PCMT), Université Gamal Abdel Nasser de Conakry (UGANC), Dixinn, PoBox 1017, Conakry, Guinea.; Faculté des sciences techniques de la santé (FSTS), Université Gamal Abdel Nasser de Conakry (UGANC), Conakry, Guinea., Pozo-Martin F; Evidence-Based Public Health, Centre for International Health Protection, Robert Koch-Institute, Nordufer 20, 13353, Berlin, Germany., Weishaar H; Evidence-Based Public Health, Centre for International Health Protection, Robert Koch-Institute, Nordufer 20, 13353, Berlin, Germany., Menelik-Obbarius S; Evidence-Based Public Health, Centre for International Health Protection, Robert Koch-Institute, Nordufer 20, 13353, Berlin, Germany., Burger G; Evidence-Based Public Health, Centre for International Health Protection, Robert Koch-Institute, Nordufer 20, 13353, Berlin, Germany., Diaconu V; Evidence-Based Public Health, Centre for International Health Protection, Robert Koch-Institute, Nordufer 20, 13353, Berlin, Germany., Dörre A; Department of Infectious Disease Epidemiology, Robert Koch-Institute, Seestraße 10, 13353, Berlin, Germany., El Bcheraoui C; Evidence-Based Public Health, Centre for International Health Protection, Robert Koch-Institute, Nordufer 20, 13353, Berlin, Germany. El-BcheraouiC@rki.de.
المصدر: Malaria journal [Malar J] 2023 Nov 20; Vol. 22 (1), pp. 355. Date of Electronic Publication: 2023 Nov 20.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101139802 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2875 (Electronic) Linking ISSN: 14752875 NLM ISO Abbreviation: Malar J Subsets: MEDLINE
أسماء مطبوعة: Original Publication: London : BioMed Central, [2002-
مواضيع طبية MeSH: Malaria Vaccines* , Malaria*/prevention & control, Humans ; Child ; Child, Preschool ; Caregivers ; Sierra Leone/epidemiology ; Cross-Sectional Studies ; Guinea ; Lot Quality Assurance Sampling ; Surveys and Questionnaires ; Vaccination
مستخلص: Background: Malaria is a leading cause of death and reduced life span in Guinea and Sierra Leone, where plans for rolling out the malaria vaccine for children are being made. There is little evidence about caregiver acceptance rates to guide roll-out policies. To inform future vaccine implementation planning, this analysis aimed to assess potential malaria vaccine acceptance by caregivers and identify factors associated with acceptance in Guinea and Sierra Leone.
Methods: A cross-sectional household survey using lot quality assurance sampling was conducted in three regions per country between May 2022 and August 2022. The first survey respondent in each household provided sociodemographic information. A household member responsible for childcare shared their likelihood of accepting a malaria vaccine for their children under 5 years and details about children's health. The prevalence of caregiver vaccine acceptance was calculated and associated factors were explored using multivariable logistic regression modelling calculating adjusted odds ratios (aOR) with 95% confidence intervals (CI).
Results: Caregivers in 76% of 702 sampled households in Guinea and 81% of 575 households in Sierra Leone were accepting of a potential vaccine for their children. In both countries, acceptance was lower in remote areas than in urban areas (Guinea: aOR 0.22 [95%CI 0.09-0.50], Sierra Leone: 0.17 [0.06-0.47]). In Guinea, acceptance was lower among caregivers living in the richest households compared to the poorest households (0.10 [0.04-0.24]), among those whose children were tested for malaria when febrile (0.54 [0.34-0.85]) and in households adopting more preventative measures against malaria (0.39 [0.25-0.62]). Better knowledge of the cause of malaria infection was associated with increased acceptance (3.46 [1.01-11.87]). In Sierra Leone, vaccine acceptance was higher among caregivers living in households where the first respondent had higher levels of education as compared to lower levels (2.32 [1.05-5.11]).
Conclusion: In both countries, malaria vaccine acceptance seems promising for future vaccine roll-out programmes. Policy makers might consider regional differences, sociodemographic factors, and levels of knowledge about malaria for optimization of implementation strategies. Raising awareness about the benefits of comprehensive malaria control efforts, including vaccination and other preventive measures, requires attention in upcoming campaigns.
(© 2023. The Author(s).)
References: Expert Rev Vaccines. 2019 May;18(5):547-558. (PMID: 30822248)
Malar J. 2021 Nov 17;20(1):438. (PMID: 34789253)
Malar J. 2022 Nov 16;21(1):339. (PMID: 36384655)
PLoS One. 2021 Feb 2;16(2):e0245059. (PMID: 33529183)
BMC Public Health. 2023 Mar 29;23(1):586. (PMID: 36991394)
PLoS One. 2018 Dec 7;13(12):e0208601. (PMID: 30532274)
Ann Transl Med. 2016 May;4(10):195. (PMID: 27294091)
Rev Panam Salud Publica. 2019 Apr 17;43:e39. (PMID: 31093263)
Malar J. 2021 Jul 27;20(1):325. (PMID: 34315489)
PLoS One. 2014 Oct 09;9(10):e109353. (PMID: 25299646)
Int J Equity Health. 2022 Dec 31;21(1):191. (PMID: 36585704)
Infect Dis Model. 2020 Jan 07;5:111-128. (PMID: 31956740)
Vaccine. 2021 Feb 12;39(7):1148-1156. (PMID: 33461834)
PLoS One. 2018 Dec 31;13(12):e0209744. (PMID: 30596732)
Malar J. 2022 May 12;21(1):146. (PMID: 35549710)
BMC Public Health. 2020 Oct 12;20(1):1539. (PMID: 33046052)
Nat Rev Dis Primers. 2021 Jun 10;7(1):41. (PMID: 34112811)
Trials. 2019 May 31;20(1):316. (PMID: 31151473)
Int J Health Plann Manage. 2022 May;37(3):1439-1453. (PMID: 34984733)
Front Public Health. 2022 May 19;10:842368. (PMID: 35664099)
Trop Med Int Health. 2015 Dec;20(12):1756-70. (PMID: 26425920)
PLoS One. 2014 Oct 15;9(10):e109707. (PMID: 25334094)
Malar J. 2016 Apr 05;15:189. (PMID: 27048260)
Public Health Rep. 2014 Jan-Feb;129 Suppl 2:19-31. (PMID: 24385661)
Malar J. 2021 Apr 13;20(1):183. (PMID: 33849572)
Int J Infect Dis. 2021 Apr;105:188-193. (PMID: 33578012)
PLoS One. 2022 Dec 1;17(12):e0278224. (PMID: 36455209)
Lancet. 2020 Oct 17;396(10258):1204-1222. (PMID: 33069326)
Vaccine. 2016 Feb 17;34(8):1018-24. (PMID: 26672676)
Malar J. 2014 May 05;13:172. (PMID: 24886650)
Vaccine. 2023 Feb 17;41(8):1503-1512. (PMID: 36725434)
Vaccine. 2016 Jan 20;34(4):408-412. (PMID: 26706273)
معلومات مُعتمدة: ZMI1-2521GHP914 Bundesministerium für Gesundheit
فهرسة مساهمة: Keywords: Caregivers; Child; Cross-sectional studies; Guinea; Immunization programs; Logistic models; Lot quality assurance sampling; Malaria vaccines; Sierra Leone; Surveys and questionnaires
المشرفين على المادة: 0 (Malaria Vaccines)
تواريخ الأحداث: Date Created: 20231121 Date Completed: 20231122 Latest Revision: 20231123
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC10662512
DOI: 10.1186/s12936-023-04783-0
PMID: 37986067
قاعدة البيانات: MEDLINE
الوصف
تدمد:1475-2875
DOI:10.1186/s12936-023-04783-0